Revolution Medicines Inc
Revolution Medicines Inc (RVMD) Implied Volatility Current
RVMD implied volatility is 45%. IV Rank is 5%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking RVMD implied volatility helps you identify when options premiums on Revolution Medicines Inc are historically cheap or expensive, and where the best trades are hiding. Revolution Medicines Inc implied volatility reflects the market's expectation of future price movement: when RVMD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Revolution Medicines Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For RVMD, tracking metrics like RVMD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on RVMD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants.
Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where RVMD implied volatility sits today versus where it has been. Our scanner ranks Revolution Medicines Inc implied volatility against its historical range, surfaces extremes in RVMD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Revolution Medicines Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 24, 2026
Trade options with IV on your side
Track RVMD IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→